AML bearing the translocation t(11;17)(q23;q21): Involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid

Annals of Hematology

Volumn 84, Issue 12, 2005, Pages 774-780

  Classen, C F ^a,b   Teigler Schlegel, A ^c   Rottgers S ^c   Reinhardt, D ^d   Dohner K ^a   Debatin, K M ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Klinikum Duisburg   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

AML; MLL; Retinoic acid; t(11; 17)

Indexed keywords

ANTINEOPLASTIC AGENT; CD15 ANTIGEN; CD33 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD71 ANTIGEN; HLA DR ANTIGEN; MIXED LINEAGE LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CELL DEATH; CELL DIFFERENTIATION; CELL STRUCTURE; CHROMOSOME 17Q; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKEMIA CELL; LEUKEMIA REMISSION; MONOCYTIC LEUKEMIA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; SCHOOL CHILD; UPREGULATION;

ANTIGENS, CD38; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL DIFFERENTIATION; CHILD; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, RETINOIC ACID; TRANSLOCATION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 29444440374     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1089-2     Document Type: Article

References (18)

1. Reeves BR, Kempski H, Jani K, Borrow J, Howe K, Solomon E, Kearney L, Cotter F (1994) A case of acute monocytic leukemia with t(11;17) involving a rearrangement of MLL -1 and a region proximal to the RARA gene. Cancer Genet Cytogenet 74:50-53 10.1016/0165-4608(94)90028-0
2. Dube S, Fetni R, Hazourli S, Champagne M, Lemieux N (2003) Rearrangement of the MLL gene and a region proximal to the RARalpha gene in a case of acute myelocytic leukemia M5 with a t(11;17)(q23;q21). Cancer Genet Cytogenet 145:54-59 10.1016/S0165-4608(03)00056-6
3. Shekhter-Levin S, Gollin SM, Kaplan SS, Redner RL (2000) Involvement of the MLL and RARalpha genes in a patient with acute monocytic leukemia with t(11;17)(q23;q12). Leukemia 14:520-522 10.1038/sj.leu.2401707
4. Daser A, Rabbitts TH (2004) Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev 18:965-974 10.1101/gad.1195504
5. Ernst P. Fisher J.K. Avery W. Wade S. Foy D. Korsmeyer S.J. 2004 Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell 6:437-443 10.1016/S1534-5807(04)00061-9
6. Prus E, Fibach E (2003) Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: Relationship with cell differentiation. Leuk Lymphoma 44:691-698 12769347
7. Purton LE, Bernstein ID, Collins SJ (1999) All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sca-1(+)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors. Blood 94:483-495 10397716
8. Schlenk RF, Frohling S, Hartmann F, Fischer JT, Glasmacher A, del Valle F, Grimminger W, Gotze K, Waterhouse C, Schoch R, Pralle H, Mergenthaler HG, Hensel M, Koller E, Kirchen H, Preiss J, Salwender H, Biedermann HG, Kremers S, Griesinger F, Benner A, Addamo B, Dohner K, Haas R, Dohner H (2004) Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia 18:1798-1803 10.1038/sj.leu.2403528
9. Collins SJ (2002) The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 16:1896-1905 10.1038/sj.leu.2402718
10. Wuchter C, Harbott J, Schoch C, Schnittger S, Borkhardt A, Karawajew L, Ratei R, Ruppert V, Haferlach T, Creutzig U, Dorken B, Ludwig WD (2000) Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1. Leukemia 14:1232-1238 10.1038/sj.leu.2401840
11. U Creutzig D Reinhardt 2004 Multizentrische therapiestudie AML-BFM 2004 Münster Germany
12. Gamerdinger U, Teigler-Schlegel A, Pils S, Bruch J, Viehmann S, Keller M, Jauch A, Harbott J (2003) Cryptic chromosomal aberrations leading to an AML1/ETO Rearrangement are frequently caused by small insertions. Genes Chromosomes Cancer 36:261-272 10.1002/gcc.10168
13. F Mitelman 1995 An international system for human cytogenetic nomenclature Karger Basel, Switzerland
14. Fischer K, Scholl C, Salat J, Frohling S, Schlenk R, Bentz M, Stilgenbauer S, Lichter P, Dohner H (1996) Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 88:3962-3971 8916963
15. Döhner K, Tobis K, Ulrich R, Föhling S, Benner A, Schlenk RF, Döhner H (2002) Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: A study of the AML Study Group ULM (AMLSG Ulm). J Clin Oncol 20:3254-3261 10.1200/JCO.2002.09.088
16. Classen CF, Gnekow A, Debatin KM (2003) Terminal differentiation in vitro of patient-derived post-TMD megakaryoblastic AML cells. Ann Hematol 82:506-510 10.1007/s00277-003-0692-3
17. Colombat P, Santini V, Delwel R, Krefft J, Bredmond JL, L̈wenberg B (1991) Primary human acute myeloblastic leukaemia: An anlaysis of in vitro granulocytic maturation following stimulation with retinoic acid and G-CSF. Br J Haematol 79:382-389 1721525
18. McGuckin CP, Pearce D, Forraz N, Tooze JA, Watt SM, Pettengell R (2003) Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur J Haematol 71:341-350 10.1034/ j.1600-0609.2003.00153.x